HederaDX
Hedera Dx | Modern cancer care for the next billion people
Epalinges, Switzerland · Founded 2021
- Headquarters
- Epalinges
- Founded
- 2021
- Business Model
- B2B
- Website
- hederadx.com
- Last Round
- Series AMay 2025
- Rounds
- 2
Indexed holds 2 funding rounds and 4 investors for this company. The full record is or through the API.
About
Hedera Dx develops in-house cancer testing solutions designed to improve oncology patient outcomes and healthcare professional experiences. Its clinicogenomics platform supplies real-world data from a decentralized global network to inform decisions and accelerate personalized therapy development. The company partners with laboratories and clinicians on locally processed, CE-IVDR-compliant, clinically actionable NGS liquid biopsies.
Summary
HederaDX is a Biotech company based in Epalinges, Switzerland, founded in 2021. Its most recent funding was a Series A round in May 2025. Investors include Vsquared Ventures, General Catalyst and 7wireVentures.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
May 2025
Sign up to see all 2 events
Funding: Seed through Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/hederadx"><img src="https://indexed.vc/api/badge/company/hederadx" alt="HederaDX on Indexed.vc" width="260" height="76" /></a>